[go: up one dir, main page]

AU2003255893A1 - USE OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPAR $f(a)) AGONIST FOR THE TREATMENT OF CARNITINE PALMITOYL TRANSFERASE-2 DEFICIENCIES - Google Patents

USE OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPAR $f(a)) AGONIST FOR THE TREATMENT OF CARNITINE PALMITOYL TRANSFERASE-2 DEFICIENCIES

Info

Publication number
AU2003255893A1
AU2003255893A1 AU2003255893A AU2003255893A AU2003255893A1 AU 2003255893 A1 AU2003255893 A1 AU 2003255893A1 AU 2003255893 A AU2003255893 A AU 2003255893A AU 2003255893 A AU2003255893 A AU 2003255893A AU 2003255893 A1 AU2003255893 A1 AU 2003255893A1
Authority
AU
Australia
Prior art keywords
ppar
agonist
deficiencies
treatment
activated receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003255893A
Inventor
Jean Bastin
Fatima Djouadi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of AU2003255893A1 publication Critical patent/AU2003255893A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003255893A 2002-09-03 2003-08-26 USE OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPAR $f(a)) AGONIST FOR THE TREATMENT OF CARNITINE PALMITOYL TRANSFERASE-2 DEFICIENCIES Abandoned AU2003255893A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40725302P 2002-09-03 2002-09-03
US60/407,253 2002-09-03
PCT/IB2003/003527 WO2004022047A1 (en) 2002-09-03 2003-08-26 USE OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPAR $f(a)) AGONIST FOR THE TREATMENT OF CARNITINE PALMITOYL TRANSFERASE-2 DEFICIENCIES

Publications (1)

Publication Number Publication Date
AU2003255893A1 true AU2003255893A1 (en) 2004-03-29

Family

ID=31978447

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003255893A Abandoned AU2003255893A1 (en) 2002-09-03 2003-08-26 USE OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPAR $f(a)) AGONIST FOR THE TREATMENT OF CARNITINE PALMITOYL TRANSFERASE-2 DEFICIENCIES

Country Status (2)

Country Link
AU (1) AU2003255893A1 (en)
WO (1) WO2004022047A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3015287B1 (en) 2013-12-19 2016-12-23 Inst Nat Sante Rech Med COMBINATION OF BEZAFIBRATE AND RESVERATROL FOR THE TREATMENT AND PREVENTION OF DISEASES INVOLVING AN ENERGY DYSFUNCTION OF MITOCHONDRIES.

Also Published As

Publication number Publication date
WO2004022047A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
IL162330A0 (en) Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar)
AU2003225027A1 (en) Combination therapy using a ppar alpha/gamma agonist
AU2859202A (en) Peroxisome proliferator activated receptor alpha agonists
AU2003287965A1 (en) Modulation of peroxisome proliferator activated receptors activity
IL158873A0 (en) Modulators of peroxisome proliferator activated receptors
PL372971A1 (en) Thiazole and oxazole derivatives that modulate ppar activity
SI1554518T1 (en) Threaded pipe with surface treatment
IL166334A0 (en) Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
AU2002224139A1 (en) Ppar (peroxisome proliferator activated receptor) activators
IL161578A0 (en) Peroxisome proliferator activated receptor agonists
IL162699A0 (en) Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2- selective inhibitors
AU2003279442A1 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
IL175310A0 (en) Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists
AU2003278814A8 (en) Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof
AU2001223488A1 (en) Activators of peroxisome proliferator-activated alpha and beta receptors as medicaments for treating skin disorders having immunological causes
SI1569634T1 (en) Use of a ppar-alpha agonist and metformin for the treatment of obesity
AU2003255893A1 (en) USE OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPAR $f(a)) AGONIST FOR THE TREATMENT OF CARNITINE PALMITOYL TRANSFERASE-2 DEFICIENCIES
ITMI20020986A1 (en) COMPOSITION BASED ON DICLOFENAC FOR THE TOPICAL TREATMENT OF AFFECTIONS OF THE OROPHARINGOUS CABLE
AU2003303376A1 (en) Cannabinoid analogs as peroxisome proliferator activated nuclear receptor gamma activators
AU2003238249A1 (en) USE OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR)-Gamma LIGANDS AS A TREATMENT FOR PITUITARY TUMORS AND ASSOCIATED CONDITIONS, SUCH AS CUSHING'S SYNDROME
AU2003277665A1 (en) Peroxisome proliferator-activated recetor ligand
AU2003296545A1 (en) Use of a trpm8-activating substance for the treatment of tumours
AU2003261927A1 (en) Peroxisome proliferator-activated receptor controllers
AU2003246187A1 (en) MEDICINAL COMPOSITION CONTAINING DIURETIC AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) Gamma ACTIAVTOR
HK1071563A (en) Peroxisome proliferator activated receptor agonists

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase